chrX-37572270-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001170331.2(LANCL3):c.400G>A(p.Val134Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000178 in 112,050 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001170331.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
LANCL3 | NM_001170331.2 | c.400G>A | p.Val134Ile | missense_variant | 1/5 | ENST00000378619.4 | |
LANCL3 | NM_198511.3 | c.400G>A | p.Val134Ile | missense_variant | 1/6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
LANCL3 | ENST00000378619.4 | c.400G>A | p.Val134Ile | missense_variant | 1/5 | 1 | NM_001170331.2 | P1 | |
LANCL3 | ENST00000378621.7 | c.400G>A | p.Val134Ile | missense_variant | 1/6 | 1 | |||
LANCL3 | ENST00000614025.4 | c.400G>A | p.Val134Ile | missense_variant | 1/5 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000178 AC: 2AN: 112050Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34232
GnomAD3 exomes AF: 0.0000308 AC: 3AN: 97528Hom.: 0 AF XY: 0.0000581 AC XY: 2AN XY: 34446
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000577 AC: 6AN: 1040699Hom.: 0 Cov.: 29 AF XY: 0.0000118 AC XY: 4AN XY: 337895
GnomAD4 genome AF: 0.0000178 AC: 2AN: 112050Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 34232
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2023 | The c.400G>A (p.V134I) alteration is located in exon 1 (coding exon 1) of the LANCL3 gene. This alteration results from a G to A substitution at nucleotide position 400, causing the valine (V) at amino acid position 134 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at